TEAMS

Director

Dr. Mariko Hirata

Dr. Mariko Hirata built her clinical foundation through extensive experience at university and general hospitals, before dedicating many years to aesthetic surgery and dermatology. She possesses exceptional expertise in injectable treatments such as hyaluronic acid and botulinum toxin, achieving natural and refined results.
At Tokyo Relife Clinic, she integrates advanced regenerative medicine with aesthetic medicine, providing cutting-edge treatments that pursue beauty and youth. Her practice is dedicated to maximizing each patient’s individual appeal, while ensuring both safety and effectiveness.

Chief Advisor [Regenerative Medicine]

Dr. Tsuyoshi Takato

After graduating from the University of Tokyo School of Medicine, he received his M.D. from the same school. He has gained extensive experience at domestic and international medical institutions. He specializes in oral and plastic surgery. Formerly Professor of Oral and Maxillofacial Surgery at the University of Tokyo Graduate School of Medicine, Department of Surgery, Division of Sensory and Motor Functional Medicine. Formerly, Director of Tissue Engineering Department, The University of Tokyo Hospital. Former Director of the 22nd Century Medical Center at the same hospital (concurrent post). Currently Director of JR Tokyo General Hospital. Director of the Department of Dental Surgery and Plastic and Reconstructive Surgery. Director of the Japanese Society for Regenerative Medicine. He has introduced clinical experience and techniques from Canada and the U.S. to Japan, and has developed many new techniques himself. He has been active for many years as a specialist in plastic and cosmetic surgery. In recent years, he has focused on research and clinical application of regenerative medicine, which has received high acclaim both in Japan and abroad. He has served as Vice President of the Japanese Society for Regenerative Medicine. He received the Achievement Award from the Japanese Society for Regenerative Medicine.

Chief Advisor [Aesthetic Medicine].

Dr. Nobutaka Furuyama

He is a pioneer in the field of cosmetic surgery, having started the practice in earnest at university hospitals in Japan and leading the industry. He specializes in "non-scalpel rejuvenation treatment," and is internationally recognized for his Botox, hyaluronic acid injections, and thread treatments for sagging skin, and contributes to the development of aesthetic medicine in Japan and abroad as head faculty of injections.

Dr. Koichi Yoshimi

After graduating from the Faculty of Medicine at Nagasaki University, Dr. Yoshimi trained in plastic surgery at Keio University Hospital. He subsequently gained extensive clinical experience in aesthetic surgery, dermatology, laser therapy, and plastic surgery. He has served as the director of major aesthetic surgery clinics, including Otsuka Aesthetic Plastic Surgery, and has long been at the forefront of Japan’s aesthetic medicine field.
He is a member of the Japan Society of Plastic and Reconstructive Surgery, the Japanese Dermatological Association, and the Japan Society for Laser Surgery and Medicine, as well as the Japan Society for Regenerative Medicine and the Japanese Society for Extracellular Vesicles. With his wealth of experience and proven skills, Dr. Yoshimi is dedicated to providing safe, effective, and individually tailored aesthetic medical treatments.

Director, Center for Cell Innovation Research and Regenerative Therapy [M.D.].

Dr. Marlen Doskali

In his home country of Kazakhstan, he is a liver surgeon and is also active in transplantation surgery. He has over 15 years of expertise and technical background in cellular immunotherapy and development of innovative therapies. He is currently the Director of the Center for Cell Innovation Research and Regenerative Therapy at Tokyo ReLife Clinic, where he oversees two important divisions: the Cell Processing Center Division and the Cell Innovation Research Division. He is an outstanding leader in the field of regenerative medicine and cell research and leads the team.

Director, Cell Innovation Research Division [Clinical Laboratory Technician, M.D.].

Dr. Yoshiyasu Shinohara

He has over 20 years of experience in cell biology, genetic testing, and regenerative medicine in academia, life science companies, and biotech companies. In addition, he is also involved in the development of new therapeutic technologies. In addition, he leads research that pushes the boundaries of cell science worldwide, while brushing up therapeutic technologies.

Associate Professor (Special Appointment), Graduate School of Science, The University of Tokyo

Mr. Hiroyuki Matsumura

Dr. Matsumura is a specially appointed associate professor in the Department of Chemistry, Graduate School of Science, The University of Tokyo, and a member of the Goda Laboratory. The Goda Lab integrates quantum science, nanotechnology, microfluidics, data science, and other fields to develop new tools in cytometry and optical science. By utilizing these technologies, the lab aims to discover unknown phenomena, elucidate mechanisms, and develop applications in science, industry, and medicine. Members of the Goda Lab, including Dr. Matsumura, have received numerous awards from academic societies, foundations, and government agencies, and Dr. Matsumura continues to be an active contributor to the team’s research.

Founder, Chief Executive Officer

Yoshiaki Furuyama

Yoshiaki Furuya is a healthcare entrepreneur who leads Tokyo Relife Clinic, specializing in regenerative medicine and longevity science. Born in Tokyo in 1984, he began his career in aesthetic medical management at Jiyugaoka Clinic, before shifting his focus to the clinical application of regenerative therapies.
Currently, he promotes advanced treatments such as stem cell therapy, exosome therapy, and senolytics (drugs for the elimination of senescent cells), aiming to control aging processes and extend healthy life expectancy. He is also actively involved in clinical research in collaboration with universities and research institutions, while expanding international medical tourism and treatment programs for high-net-worth patients. His guiding principle is the promotion of “evidence-based longevity medicine that patients can trust.”